Imipramine triiodothyronine

therapy. The administration of triiodothyronine (T3) to antidepressant nonresponders can be an Coadministration of imipramine and T3 results in desensitiza- Imipramine was administered to thyroidectomized, hypophysectomized, triiodothyronine-treated and euthyroid-control rats for 7 days. The distribution of

Triiodothyronine (T3) is effective in both augmenting and accelerating the with imipramine on 5-HT levels in the hypothalamus and on 5-HT(1A) and 5-HT(1B)

Chronic Effects of Triiodothyronine in Combination with Imipramine on 5-HT Triiodothyronine (T3) has been shown to accelerate and potentiate the clinical Clinical studies have shown that triiodothyronine (T3) both augments and accelerates the therapeutic response to antidepressant drugs, particularly tricyclics Research from JAMA Pediatrics Triiodothyronine Thyrotoxicosis At this time, imipramine therapy was discontinued and the patient again became clinically

Effect of triiodothyronine (T ) augmentation of acute ... - ResearchGate

(triiodothyronine, abbreviated as TS here- after) and found that the effect appeared earlier than in the case of administration of imipramine alone. Since then, a imipramine. produces a more rapid recovery from depression than does imipramine alone. It seems more potent than triiodothyronine in potentiating imipramine,

Although triiodothyronine (T3) is widely used clinically, preclinical support for its (2002) Effects of triiodothyronine and imipramine on basal 5-HT levels and Prange AJ Jr, Wilson IC, Rabon AM, et al: Enhancement of imipramine by triiodothyronine in unselected depressed patients, in Cerletti A, Bove FJ (eds): The